Presenting Author |
Abstract Title |
Talk/Poster |
Aldarouish, Mohanad |
Ubiquitinated proteins
enriched from tumor cells by a ubiquitin binding
protein Vx3(A7) as a potent cancer vaccine |
poster |
Bae, Yong-Soo |
Dendritic cell-based tumor
immunotherapy from bench to bedside |
talk |
Berhani, Orit |
Vigilin regulates the
expression of the stress-induced ligand MICB by
interacting with its 5’ UTR |
talk |
Bhardwaj, Nina |
Targeting innate immune
cells to improve immunity |
talk |
Biswas, Subhra |
Monocytes and
macrophages—New insights from their study in tumor
progression |
talk |
Bosselut, Remy |
Post-thymic control of
helper vs. cytotoxic effector T cell differentiation
by the transcription factor Thpok—Implications for
tumor immunotherapy |
talk |
Cao, Guoshuai |
Tumor therapeutics work as
stress inducers to enhance tumor sensitivity to NK
cell cytolysis by upregulating NKp30 ligand B7-H6 |
poster |
Cao, Rui |
Effect of TRPM7 on human
bladder cancer cell proliferation, migration and
invasion via MAPK and PI3K/AKT signaling pathways |
poster |
Cao, Xuetao |
Characterization of a new
cell population in cancer progression |
talk |
Chen, Jingtao |
Cyclin D1, a target for
mantle cell lymphoma |
poster |
Chen, Lieping |
Perspectives on
anti-PD-L1/PD-1 therapy for advanced human cancers |
talk |
Chen, Liuh-yow |
Human TIN2 isoforms in
telomerase regulation |
poster |
Chen, Shihao |
Combination of 4-1BB
agonist and PD-1 antagonist promotes anti-tumor
effector / memory CD8 T cells in a poorly
immunogenic tumor model |
talk |
Chen, Siqi |
A targeting IL-15 fusion
protein for cancer immunotherapy |
poster |
Chester, Cariad |
Microarray analysis
identifies a reovirus infection-induced activation
signature in natural killer cells |
poster |
Cui, Weiguo |
A Multi-pronged approach
to fight solid tumors |
talk |
Deng, Xuewen |
Adoptive transfer of
expanded CD56-bright NK cells increases CD56-dim NK
cells in peripheral blood and augments the
cytotoxicity of PBMCs |
poster |
Duev-Cohen, Alexandra |
N-linked sugars on 2B4 and
NTB-A co-stimulatory receptors are crucial to
killing of tumor cells by NK cells |
poster |
Feng, Zipei |
Analysis of the
relationship between CD8+ T cells and FoxP3+ T cells
within the tumor immune-environment predicts outcome
of patients with head and neck cancer |
talk |
Finn, Olivera |
MUC1 vaccine for colon
cancer prevention—Microarray and bioinformatic
analysis of pre-vaccination gene signatures
distinguish responders from non-responders |
talk |
Gariepy, Jean |
A vaccine-induced Th9
immune response that blocks the engraftment and
formation of metastatic tumour foci in vivo |
talk |
Glasner, Ariella |
The NK killer receptor
Ncr1 shapes tumor architecture to prevent metastasis |
talk |
Gong, Chenyuan |
A high-throughput assay
for identifying NK cell-activated natural products |
poster |
Han, Yanyan |
Immunotherapy with
patient-specific antigens selection reduced the
metastasis of a cervical cancer patient |
poster |
He, Wei |
Identification for γδ T
cell recognized ligands by tumor specific CDR3δ and
its application in tumor immunotherapy |
poster |
Hong, Jung-Hyub |
CISH-deficient mice
resistant to DSS-induced colitis in association with
DC-mediated mucosal tolerance |
poster |
Hu, Qingxuan |
Alterations and effects of
PPARs and Sirtuins in the mouse and human testis
with inflammation |
poster |
Hu, Yang |
Protein translation
inhibitors as drug target for the treatment of
hepatocellular carcinoma |
poster |
Huang, Weishan |
The TCR/ITK signaling
tunes CD8+ T cell metabolism, homeostatic
proliferation, and anti-tumor effector function |
poster |
Hwang, Inkyu |
Combination cancer therapy
using IL-2 and a TGF-β signaling inhibitor |
poster |
Jiang, Hui-Rong |
Interleukin-33 promotes
ovarian cancer cell growth and metastasis through
regulating MAPK signaling pathways |
poster |
Kalthoff, Holger |
Interleukin-6
trans-signaling increases the expression of
carcinoembryonic antigen-related cell adhesion
molecule 5 and 6 in colorectal cancer cells |
talk |
Kang, Myeong-Ho |
A negative regulator Dab2
can be a molecular target for improvement of
DC-based tumor vaccine |
poster |
Kawamoto, Hiroshi |
Cloning and expansion of
antigen specific T cells using the iPSC technology—A
novel strategy for cancer immunotherapy |
talk |
Leng, Chih-Hsiang |
Toll-like receptor 9
agonist enhances anti-tumor immunity and inhibits
tumor-associated immunosuppressive cells numbers in
a mouse cervical cancer model following recombinant
lipoprotein therapy |
poster |
Li, Jing |
Differential expression of
PD-1 and Tim-3 marks activated versus exhausted T
cells in the tumor microenvironment |
poster |
Li, Li |
A novel bispecific
antibody S-Fab induces potent cancer cell killing |
poster |
Li, Ming |
Immunity and tolerance in
cancer |
talk |
Li, Shun |
Tumor suppressor PTEN
plays a critical role in IRF3-mediated antiviral
innate immunity |
talk |
Li, Wenjun |
Two HTRF assays for
PD1/PD-L1 protein/protein interaction |
poster |
Lin, Rongtuan |
Modulating the antioxidant
defences to potentiate oncolytic virotherapy in
prostate cancer |
poster |
Liu, Feng |
Genome-wide identification
and characterization of enhancer RNAs in human
genome—Implications for human autoimmune disease |
poster |
Liu, Shih-Jen |
Gemcitabine
synergistically enhances anti-tumor effects of
recombinant immunogen-based cancer immunotherapy |
poster |
Lu, Binfeng |
IL-36γ promotes antitumor
immune responses |
talk |
Lu, Bo |
The Smac mimetic Debio
1143 synergizes with radiotherapy and immune
checkpoint inhibitors to enhance antitumor immunity |
poster |
MA, Yuting |
STAT3 depletion enhances
tumor cell immunogenicity |
talk |
Mandelboim, Ofer |
Strategies used by
bacteria to avoid Natural Killer cell attack |
talk |
Möller, Andreas |
Myeloid-derived suppressor
cell-mediated immune regulation at metastatic sites
and pre-metastatic niches |
talk |
Nguyen, Thi Minh Nguyet |
Combination cancer therapy
using IL-2 and a TGF-β signaling inhibitor |
poster |
Park, Yu-jin |
Dab2-overexpression makes
DCs become tolerogenic and effective for the
treatment of collagen-induced arthritis in mice |
poster |
Platten, Michael |
Concepts for brain tumor
vaccines |
talk |
Qian, Kaiyu |
The role of PSA-TRPM8
pathway in prostate cancer metastasis |
poster |
Qin, Zhihai |
Novel myeloid cell types
in tumor microenvironment |
talk |
Rhee, Joon Haeng |
Flagellin is a strong
vaginal adjuvant for therapeutic vaccine in genital
cancer |
talk |
Sadelain, Michel |
CAR therapy—The CD19
paradigm |
talk |
Sakaguchi, Shimon |
Targeting Treg subsets for
cancer immunotherapy |
talk |
Shen, Chen |
PEI derived polymers as
vaccine adjuvants (Review) |
poster |
Sher, Yuh-Pyng |
A HLA-A2-restricted CTL
epitope induces anti-tumor effects against human
lung cancer in mouse xenograft model |
poster |
Slaney, Clare |
Using dual-specific
chimeric antigen receptor (CAR) T cells and
genetically modified virus to eliminate large
established Her2+ tumors |
talk |
Srivastava, Pramod |
Define a true
tumor-specific epitope for effective cancer
immunotherapy |
talk |
Tan, Binghe |
Rspo-Lgr4 impairs CD8+
T cell mediated tumor suppression by switching tumor
associated macrophage polarization |
talk |
Tang, I-Chung |
Targeting colorectal
cancer stem-like cells using CD133
antibody-conjugated SN-38 nanoparticles |
poster |
Taniguchi, Tadatsugu |
Regulation of inflammation
and anti-tumor innate immunity by self-derived
molecules |
talk |
Thielemans, Kris
|
Clinical trials with mRNA
electroporated autologous dendritic cells for stage
III/IV melanoma patients |
talk |
Wang, Gang |
Inhibition of simvastatin
on epithelial mesenchymal transition (EMT) in
bladder cancer cells and its inducing effect on
G1/G0 phase cell cycle arrest by reducing cyclin D1
and CDK4/6 protein abundance |
poster |
Wang, Haopeng |
Explore new cancer
therapeutic targets in T cell costimulation pathway
using phosphoproteomic and genetic approaches |
poster |
Wang, Qingqing |
Interleukin 33 in tumor
microenvironment is crucial for the accumulation and
function of myeloid-derived suppressor cells |
talk |
Wang, Rongfu |
Immune targets and their
regulatory mechanisms in cancer immunotherapy |
talk |
Wang, Ying |
Tylophorine analogs
inhibited protein translation through modulating
interaction of HSC70 and HSP40 |
poster |
Wei, Bin |
ADAP and SKAP55 regulate
PD-1 expression in CD8+ cytotoxic T
lymphocytes and the efficacy of anti-tumor
immunotherapy |
talk |
Wei, Haiming |
Cytokine-mediated ex vivo
differentiated NK cells have high cytotoxity toward
leukemia cells through SLAM-SLAML interaction |
poster |
Wu, Chong |
Tumors promote the
recruitment and expansion of hematopoietic stem and
progenitor cells in the spleen |
poster |
Xie, Jun |
Lipid-enveloped hollow
mesoporous silica nanoparticles for hydrophilic and
hydrophobic immunogenic peptides co-delivery to
induce antitumor immunity |
poster |
Xu, Jing |
Development of
nanoparticles with controlled release of
cancer-associated antigens and adjuvants as
next-generation cancer vaccines |
poster |
Yang, An-Gang |
Reciprocal regulation
between c-Myc/EZH2 and miR-26a dictates pathogenesis
and invasion of hepatic cancers |
poster |
Yu, Di |
Adenovirus transduced
allogeneic dendritic cells as adjuvants for cancer
immunotherapy |
poster |
Yu, Guangjie |
purified ubiquitinated
proteins from tumor cell lysates as substrates for
DC mediated antigen cross presentation and human
T-cell activation |
poster |
Zhang, Yi |
MAGE-A3 reactive T cells
are predictive for better survival of patients with
esophageal squamous cell carcinoma |
poster |
Zhang, Yi |
Metformin improves cancer
prognosis through inhibiting myeloid-derived
suppressive cells recruitment |
talk |
Zhang, Yi |
Tumor-associated
macrophages promote cancer stem cell-like properties
via interlukin-10 in non-small cell lung cancer |
poster |
Zhang, Zhihong |
Targeting dendritic cells
in lymph node with antigen peptide-carried lipid
nanoparticle vaccine for immunotherapy |
talk |
Zheng, Xiaohu |
LunX promotes lung cancer
via inflammation |
poster |
Zhou, Weijun |
Two peptides derived from
Eps8 display anti-cancer activity as peptide vaccine
and peptide inhibitor |
poster |
Zitvogel, Laurence |
Gut microbiota and
anticancer immune responses |
talk |
Zou, Weiping |
Epigenetic regulation
shapes tumor immunity, immunotherapy and patient
outcome |
talk |